« The Supreme Court to Determine Whether Pharmaceutical Sales Representatives are Entitled to Overtime Pay | Main | Google+ Pages: Should the Life Sciences Industry be Concerned? »

12/15/2011

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

online reviews

Many in industry have been working frantically to meet the January 1, 2012 deadline to begin data collection, and perhaps some companies will forge ahead as planned and begin collecting, and perhaps voluntarily reporting their spend as of January 1. For others, the proposed delay may be a welcome reprieve and an opportunity to prepare for compliance, now with the added benefit of the proposed rule. Either way, Happy Holidays!

pharma reviews

The Federal Sunshine Law requires manufacturers of drugs, biologics, devices and medical supplies covered under Medicare, Medicaid and the Children's Health Insurance Program to report payments and other transfers of value made to physicians and teaching hospitals to CMS for subsequent public disclosure.

The comments to this entry are closed.

Enter your email address:

Pharmaspective

CONTRIBUTORS

Learn more About Us

Porzio's Blogs

Pete's Take

Related Posts Plugin for WordPress, Blogger...